Tech Company Financing Transactions
Centrexion Therapeutics Funding Round
On 11/26/2013, Centrexion Therapeutics raised $14.7 million in Series B funding from private investors.
Transaction Overview
Company Name
Announced On
11/26/2013
Transaction Type
Venture Equity
Amount
$14,728,886
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 State St.
Boston, MA 02109
USA
Boston, MA 02109
USA
Phone
Website
Email Address
Overview
We are advancing a valuable, unique and diversified pipeline of non-opioid treatments for chronic pain through internal development and strategic in-licensing. Using insights into the biology of pain and the knowledge mined from big data and translational science, we are focused on transforming pain management with real innovation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Sol Barer
Chief Executive Officer
Jeffrey Kindler
Chief Medical Officer
Randall Stevens
Chief Scientific Officer
James Campbell
VP - Bus. Development
Kerrie Brady
Browse more venture capital transactions:
Prev: 11/26/2013: Monster Digital venture capital transaction
Next: 11/26/2013: NexGen Medical venture capital transaction
Share this article
News on VC Transactions
We do our best to record funding rounds that are announced publicly. VC transactions on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs